Low bone mineral density in institutionalized patients with HIV and psychiatric co-morbidity

Infezioni in Medicina

Volumn 16, Issue 2, 2008, Pages 86-90

  De Socio, Giuseppe V L ^a   Fabbriciani, Gianluigi ^b   Fanelli, Luca ^c   Leli, Christian ^b   Callarelli, Laura ^b   Scarponi, Anna Maria ^b  

^a SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c Residential Care Facility D Dante Savini   (Italy)

Author keywords

Antipsychotic medication; Antiretroviral therapy; HIV; Osteopenia; Osteoporosis; Psychiatric disorders

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; METHADONE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BONE DENSITY; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERM CARE; MALE; OSTEOPENIA; OSTEOPOROSIS; PATHOLOGIC FRACTURE; PSYCHOSIS; RISK ASSESSMENT;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIPSYCHOTIC AGENTS; BODY MASS INDEX; BONE DENSITY; BONE DISEASES, METABOLIC; COMORBIDITY; CROSS-SECTIONAL STUDIES; DATA INTERPRETATION, STATISTICAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; OSTEOPOROSIS; PILOT PROJECTS; TIME FACTORS;

EID: 47149094675     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Brown T.T., Qaqish R.B. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS. 20, 2165-2174, 2006.
2. Meliert W., Kleinshmidt A., Schmidt J., et al. Infection of human fibroblasts and osteoblast-like cells with HIV-1. AIDS. 4, 527-535, 1990.
3. Madeddu G., Spanu A., Solinas P., et al. Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy. Q. J. Nucl. Med. Mol. Imaging 48, 39-48, 2004.
4. Vescini F., Borderi M., Buffa A., et al. Bone mass in HIV-infected patients: focus on the role of therapy and sex. J. Acquir. Immune Defic.Syndr. 33, 405-407, 2003.
5. Gold J., Pocock N., Li Y. Bone mineral density abnormalities in patients with HIV infection. J. Acquir. Immune Defic. Syndr. 30, 131-132, 2002.
6. Tomazic J., Ul K., Volcanšcek G., Gorenšek S., et al. Prevalence and risk factors for osteopenia/osteoporosis in an-HIV infected male population. Wien Klin. Wochenschr. 119, 639-646, 2007.
7. Michelson D., Stratakis C., Hill L., et al. Bone mineral density in women with depression. N. Engl. J. Med. 335, 1176-1181, 1996.
8. Hummer M., Malik P., Gasser R.W., et al. Osteoporosis in patients with schizophrenia. Am. J. Psychiatry. 162, 162-167, 2005.
9. Meaney A.M., Smith S., Howes O.D. et al. Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia. Br. J. Psychiatry. 184, 503-508, 2004.
10. Prior J., Burdge D., Maan E., et al. Fragility fractures and bone mineral density in a HIV-positive women: a case-control population based study. Osteoporos, Int, 18, 1345-1353, 2007.
11. Pence B.W., Miller W.C., Whetten K., Eron J.J., Gaynes B.N. Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States. J. Acquir. Immune Defic. Syndr. 42, 298-306, 2006.
12. Bing EG, Burnam MA, Longshore D et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 58: 721-728, 2001.
13. Thompson A., Silverman B., Dzeng L., Treisman G. Psychotropic medications and HIV. Clin. Infect. Dis. 42, 1305-1310, 2006.
14. De Socio G.V. Schizophrenia, drug therapy, and monitoring. N. Engl. J. Med. 350, 415-416, 2004.
15. Bilici M., Cakirbay H., Guler M., Tosun M., Ulgen M., Tan U. Classical and atypical neuroleptics, and bone mineral density, in patients with schizophrenia. Int. J. Neurosci. 112, 817-828, 2002.
16. Naidoo U., Goff D.C., Klibanski A. Hyperprolacrinemia and bone mineral density: the potential impact of antipsychotic agents. Psychoneuroendocrinology. 28, 97-108, 2003
17. Pouwels S., de Vries F., Egberts A.C., Leufkens H.G.M., van Staa T.P. Use of Antipsychotic and risk of hip/femur fractures: a population based case-control study. Calcif. Tissue Int. 80 (Suppl 1), P489-M, s168, 2007.
18. De Socio G.V., Fanelli L., Longo A., Stagni G. Adherence to antiretroviral therapy in HIV patients with psychiatric comorbidity. J. Acquir. Immune Defic. Syndr. 36, 1109-1110, 2004.
19. Genant H.K., Gramp S., Johnston C.C. Jr, et al. Universal standardization for dual x-ray absorptiometry: Patient and phantom cross-calibration result. J. Bone Miner. Res. 9, 1503-1514, 1994
20. Introduction to understand bone densitometry. The International Society for Clinical Densitometry. Available on http://www.iscd.org. On Line from November 2006.
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington DC.: American Psychiatric Association, 1994.
22. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO Study Group. Geneva: World Health Organization 1994.
23. Knobel H, Guelar A, Valdecillo G, Nogues X, Diez A. Osteopenia in HIV-infected patients: Is it the disease or is it treatment? AIDS. 15: 807-808, 2001.
24. Landonio S., Quirino T., Bonfanti P., et al. Osteopenia and osteoporosis in HIV+ patients, untreated or receiving HAART. Biomed. Pharmacother. 58, 505-508, 2004.
25. Bruera D., Luna N., David D.O., Bergoglio L.M., Zamudio J. Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy. AIDS 17, 1917-1923, 2003.
26. Thomas J., Doherty S.M. HIV Infection-A Risk Factor for Osteoporosis. J. Acquir. Immune Defic. Syndr. 33, 281-291, 2003.
27. Dolan S.E., Huang J.S., Killilea K.M. et al. Reduced bone density in HIV-infected women. AIDS 18, 475-483, 2004.
28. Seminari E., Castagna A., Soldatini A., et al. Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients. HIV Med. 6, 145-150, 2005.
29. Schrager S., Kloss C., Ju A.W. Prevalence of fractures in women with intellectual disabilities: a chart review. J. Intellect. Disabil. Res. 51, 253-259, 2007.